Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

Drug Development

      FDA Grants Approval for CAPLYTA for MDD Treatment in Adults

      Americas
      Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has granted approval for CAPLYTA (lumateperone) to be used as an adjunctive...

      Building the Right Team and Resource Model to Support Quality System and Validation Activities

      Drug Development
      Since life science quality and validation projects can vary widely in scope and complexity, each specific project needs to be evaluated in order to...

      Merck and Blackstone Enter R&D Funding Agreement for sac-TMT

      Clinical Trials
      Merck, recognized as MSD outside the U.S. and Canada, has announced a funding arrangement with Blackstone Life Sciences to support the development of sacituzumab...

      FDA Approves J&J’s DARZALEX FASPRO for HR-SMM in Adults

      Americas
      Johnson & Johnson said the U.S. Food and Drug Administration (FDA) has cleared DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for use as a single-agent treatment...

      FDA Approves UCB’s KYGEVVI for Thymidine Kinase 2 Deficiency

      Americas
      UCB, a leading global biopharmaceutical company, has announced that KYGEVVI has received FDA approval for the treatment of adults and pediatric patients diagnosed with...

      Lilly, NVIDIA Partner on AI Supercomputer for Drug Research

      Americas
      Eli Lilly and Company has revealed plans to construct what it calls the most powerful supercomputer ever built and operated by a pharmaceutical company,...

      FDA Unveils Initiative for Faster Biosimilar Development

      Americas
      The U.S. Food and Drug Administration (FDA) has unveiled a major initiative aimed at cutting both the time and cost required to develop biosimilar...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.